me-check® pro: Data and Firsthand Experiences With a Novel AI-Powered Screening Solution for MGD
Can AI add meibomian gland dysfunction (MGD) and ocular surface disease screening to abilities? In this booth talk, Associate professor…
Notal Vision’s AI-Powered Home OCT Gains FDA De Novo Authorization
Notal Vision (Virginia, USA) announced on May 16 that the U.S. Food and Drug Administration (FDA) has granted De Novo…
latest posts
